PD-1, PD-L1 and BIM as predictors of sentinel lymph node metastasis in primary cutaneous melanoma

Схожие документы

• β3 integrin immunohistochemistry as a method to predict sentinel lymph node status in patients with primary cutaneous melanoma
  по: Quattrocchi, Enrica, et al.
  Опубликовано: (2020)
• The Role of Integrins in Melanoma: A Review
  по: Arias-Mejias, Suzette M., et al.
  Опубликовано: (2020)
• Model Combining Tumor Molecular and Clinicopathologic Risk Factors Predicts Sentinel Lymph Node Metastasis in Primary Cutaneous Melanoma
  по: Bellomo, Domenico, et al.
  Опубликовано: (2020)
• Primary cutaneous melanoma risk stratification using a clinicopathologic and gene expression model: a pilot study
  по: Arias‐Mejias, Suzette M., et al.
  Опубликовано: (2020)
• Validation of CP‐GEP (Merlin Assay) for predicting sentinel lymph node metastasis in primary cutaneous melanoma patients: A U.S. cohort study
  по: Yousaf, Ahmed, et al.
  Опубликовано: (2021)